4.7 Article

Severe influenza pneumonitis in children with inherited TLR3 deficiency

Journal

JOURNAL OF EXPERIMENTAL MEDICINE
Volume 216, Issue 9, Pages 2038-2056

Publisher

ROCKEFELLER UNIV PRESS
DOI: 10.1084/jem.20181621

Keywords

-

Funding

  1. National Center for Advancing Translational Sciences, National Institutes of Health, Clinical and Translational Science Award program [UL1TR001866]
  2. National Institute of Allergy and Infectious Diseases, National Institutes of Health [R01AI088364, R21AI137371]
  3. National Institute of Neurological Disorders and Stroke, National Institutes of Health [R01NS072381]
  4. Cooperative Center on Human Immunology, National Institute of Allergy and Infectious Diseases [U19AI111825]
  5. Rockefeller University
  6. French National Research Agency under the Investments for the future program [ANR-10-IAHU-01]
  7. Integrative Biology of Emerging Infectious Diseases Laboratory of Excellence [ANR-10-LABX-62-IBEID]
  8. Institut National de la Sante et de la Recherche Medicale, Paris Descartes University
  9. IEIHSEER [ANR-14-CE14-0008-01]
  10. Center for Research on Influenza Pathogenesis, an National Institute of Allergy and Infectious Diseases [HHSN272201400008C]
  11. St. Giles Foundation
  12. Thrasher Research Fund
  13. Medical Scientist Training Program grant from the National Institute of General Medical Sciences, National Institutes of Health [T32GM007739]
  14. Fonds voor Wetenschappelijk Onderzoek Vlaanderen project [G0C8517N]
  15. Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health
  16. NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001222] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Autosomal recessive IRF7 and IRF9 deficiencies impair type I and III IFN immunity and underlie severe influenza pneumonitis. We report three unrelated children with influenza A virus (IAV) infection manifesting as acute respiratory distress syndrome (IAV-ARDS), heterozygous for rare TLR3 variants (P5545 in two patients and P680L in the third) causing autosomal dominant (AD) TLR3 deficiency. AD TLR3 deficiency can underlie herpes simplex virus-1 (HSV-1) encephalitis (HSE) by impairing cortical neuron-intrinsic type I IFN immunity to HSV-1. TLR3-mutated leukocytes produce normal levels of IFNs in response to IAV. In contrast, TLR3-mutated fibroblasts produce lower levels of IFN-beta and -lambda, and display enhanced viral susceptibility, upon IAV infection. Moreover, the patients' iPSC-derived pulmonary epithelial cells (PECs) are susceptible to IAV. Treatment with IFN-a2b or IFN-lambda 1 rescues this phenotype. AD TLR3 deficiency may thus underlie IAV-ARDS by impairing TLR3-dependent, type I and/or III IFN-mediated, PEC-intrinsic immunity. Its clinical penetrance is incomplete for both IAV-ARDS and HSE, consistent with their typically sporadic nature.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available